These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23104235)

  • 21. A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909.
    Rothman RB; Glowa JR
    Mol Neurobiol; 1995; 11(1-3):1-19. PubMed ID: 8561954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors.
    Gilbert JG; Newman AH; Gardner EL; Ashby CR; Heidbreder CA; Pak AC; Peng XQ; Xi ZX
    Synapse; 2005 Jul; 57(1):17-28. PubMed ID: 15858839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice.
    Song R; Yang RF; Wu N; Su RB; Li J; Peng XQ; Li X; Gaál J; Xi ZX; Gardner EL
    Addict Biol; 2012 Mar; 17(2):259-73. PubMed ID: 21507153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine D₃ receptor antagonism--still a therapeutic option for the treatment of schizophrenia.
    Gross G; Wicke K; Drescher KU
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Feb; 386(2):155-66. PubMed ID: 23128852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.
    Banasikowski TJ; Beninger RJ
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):761-8. PubMed ID: 22410316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conditioned and sensitized responses to stimulant drugs in humans.
    Leyton M
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Nov; 31(8):1601-13. PubMed ID: 17888557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.
    Keck TM; John WS; Czoty PW; Nader MA; Newman AH
    J Med Chem; 2015 Jul; 58(14):5361-80. PubMed ID: 25826710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occupancy of brain dopamine D3 receptors and drug craving: a translational approach.
    Mugnaini M; Iavarone L; Cavallini P; Griffante C; Oliosi B; Savoia C; Beaver J; Rabiner EA; Micheli F; Heidbreder C; Andorn A; Merlo Pich E; Bani M
    Neuropsychopharmacology; 2013 Jan; 38(2):302-12. PubMed ID: 22968817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine D3 receptor ligands for the treatment of tobacco dependence.
    Le Foll B; Goldberg SR; Sokoloff P
    Expert Opin Investig Drugs; 2007 Jan; 16(1):45-57. PubMed ID: 17155853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
    Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
    J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism.
    Nunes EJ; Randall PA; Santerre JL; Given AB; Sager TN; Correa M; Salamone JD
    Neuroscience; 2010 Sep; 170(1):268-80. PubMed ID: 20600675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats.
    Millan MJ; Seguin L; Gobert A; Cussac D; Brocco M
    Psychopharmacology (Berl); 2004 Jul; 174(3):341-57. PubMed ID: 14985929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The dopamine D3 receptor and drug dependence: effects on reward or beyond?
    Le Foll B; Goldberg SR; Sokoloff P
    Neuropharmacology; 2005 Sep; 49(4):525-41. PubMed ID: 15963538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a D3 receptor antagonist on context-induced reinstatement of nicotine seeking.
    Sabioni P; Di Ciano P; Le Foll B
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():149-54. PubMed ID: 26279138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of the binding and functional properties of extended length D3 dopamine receptor-selective antagonists.
    Furman CA; Roof RA; Moritz AE; Miller BN; Doyle TB; Free RB; Banala AK; Paul NM; Kumar V; Sibley CD; Newman AH; Sibley DR
    Eur Neuropsychopharmacol; 2015 Sep; 25(9):1448-61. PubMed ID: 25583363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine D1 and D3 receptor interactions in cocaine reward and seeking in rats.
    Galaj E; Harding W; Ranaldi R
    Psychopharmacology (Berl); 2016 Dec; 233(23-24):3881-3890. PubMed ID: 27582181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopaminergic modulation of risk-based decision making.
    St Onge JR; Floresco SB
    Neuropsychopharmacology; 2009 Feb; 34(3):681-97. PubMed ID: 18668030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of the adenosine A(2A) receptor-dopamine D(2) receptor interaction in drug addiction.
    Filip M; Zaniewska M; Frankowska M; Wydra K; Fuxe K
    Curr Med Chem; 2012; 19(3):317-55. PubMed ID: 22335511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of 50-kHz ultrasonic vocalizations by dopamine receptor subtype-selective agonists and antagonists in adult rats.
    Scardochio T; Clarke PB
    Psychopharmacology (Berl); 2013 Apr; 226(3):589-600. PubMed ID: 23192317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dopamine D(3) receptor antagonist YQA14 that inhibits the expression and drug-prime reactivation of morphine-induced conditioned place preference in rats.
    Hu R; Song R; Yang R; Su R; Li J
    Eur J Pharmacol; 2013 Nov; 720(1-3):212-7. PubMed ID: 24436985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.